Retour sur lavenir.net
   CFE 13.450 € (+4,67 %)     AB INBEV 73.780 € (-0,89 %)     ARGENX SE 781.800 € (+4,43 %)     KBC ANCORA 80.400 € (+0,12 %)     WDP 22.280 € (-0,71 %)     ONTEX GROUP 2.520 € (+1,61 %)     RETAIL ESTATES 69.800 € (-0,99 %)     PROXIMUS 6.105 € (-0,49 %)     BIOTALYS 3.170 € (+0,32 %)     XIOR 26.400 € (-0,19 %)     CENERGY 24.220 € (-0,41 %)     MELEXIS 79.100 € (-0,32 %)     JENSEN-GROUP 83.000 € (+2,72 %)     BELYSSE GROUP 0.524 € (-2,96 %)     BREDERODE 103.200 € (+0,98 %)     CMB.TECH 13.140 € (-4,78 %)     VIOHALCO 19.500 € (-5,34 %)     TESSENDERLO 19.880 € (+0,10 %)     RECTICEL 10.860 € (0,00 %)     KBC 117.850 € (+0,90 %)     TINC 11.380 € (-1,39 %)     ELIA GROUP 139.700 € (+3,64 %)     CARE PROPERTY INV. 12.540 € (-0,32 %)     SOFINA 219.200 € (-0,81 %)     WHAT'S COOKING GP 144.500 € (-0,34 %)     CIE BOIS SAUVAGE 302.000 € (+1,00 %)     ACKERMANS V.HAAREN 287.000 € (+0,35 %)     VAN DE VELDE 30.200 € (0,00 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     GIMV 44.250 € (+0,11 %)     D'IETEREN GROUP 173.500 € (+3,71 %)     DEME GROUP 177.400 € (-0,78 %)     EVS 27.900 € (-1,24 %)     SHURGARD 25.500 € (+0,99 %)     NYXOAH 1.476 € (+3,07 %)     TUBIZE-FIN 219.800 € (+1,01 %)     DECEUNINCK 2.220 € (+0,91 %)     COFINIMMO 83.150 € (+3,10 %)     UCB 256.600 € (+0,63 %)     GBL 79.100 € (-0,75 %)     BARCO 8.425 € (-0,77 %)     SIPEF 92.600 € (+0,22 %)     CAMPINE 214.000 € (-0,93 %)     KINEPOLIS GROUP 35.650 € (+0,71 %)     BPOST 1.560 € (-0,13 %)     SOLVAY 26.980 € (-0,30 %)     SYENSQO 67.000 € (+2,76 %)     MONTEA 66.100 € (-1,78 %)     CELYAD ONCOLOGY 0.250 € (0,00 %)     ECONOCOM GROUP 1.490 € (-1,00 %)     VGP 84.300 € (+1,57 %)     IBA 16.660 € (+2,33 %)     BEKAERT 40.250 € (+0,37 %)     QRF 11.050 € (-0,90 %)     TITAN S.A. 53.300 € (-0,65 %)     ASCENCIO 52.300 € (0,00 %)     UMICORE 21.300 € (+1,33 %)     HOME INVEST BE. 19.340 € (+0,10 %)     AGEAS 69.400 € (+0,73 %)     IMMOBEL 22.800 € (+0,88 %)  
   EXOSENS 52.650 € (-4,53 %)     EUTELSAT COMMUNIC. 2.160 € (-6,90 %)     STMICROELECTRONICS 65.060 € (+2,68 %)     ASML HOLDING 1 594.000 € (+2,59 %)     GROUPE LDLC 11.840 € (+2,96 %)     GOLD BY GOLD 4.000 € (+0,76 %)     AIRBUS 195.080 € (-0,01 %)     INVIBES ADVERTSING 0.670 € (-1,47 %)     REXEL 37.300 € (+1,22 %)     ASR NEDERLAND 66.040 € (-0,03 %)     SOITEC 112.250 € (+4,61 %)     SEMCO TECHNOLOGIES 48.350 € (-0,51 %)     POSTNL 0.916 € (+0,94 %)     COMPAGNIE ODET 1 492.000 € (+0,81 %)     CEGEDIM 11.200 € (+1,45 %)     XILAM ANIMATION 5.560 € (-10,32 %)     MEDIANTECHNOLOGIES 4.380 € (-8,08 %)     HEINEKEN 73.220 € (-1,80 %)     B.COM.PORTUGUES 1.024 € (0,00 %)     GENFIT 9.570 € (-8,51 %)     LECTRA 16.680 € (+3,09 %)     THALES 218.400 € (-3,06 %)     EXAIL TECHNOLOGIES 93.150 € (-5,81 %)     VICAT 66.900 € (+1,06 %)     CSG 12.350 € (-3,39 %)     ARCADIS 33.040 € (-0,60 %)     ARCELORMITTAL SA 54.280 € (+0,11 %)     BOUYGUES 50.140 € (+1,21 %)     ENTECH 10.560 € (-0,56 %)     ACCSYS 0.882 € (-2,00 %)     WOLTERS KLUWER 55.820 € (-0,78 %)     DSM FIRMENICH AG 80.500 € (-0,59 %)     2CRSI 25.480 € (-4,21 %)     KERING 267.900 € (+0,96 %)     STEF 116.000 € (-0,34 %)     EXEL INDUSTRIES 20.600 € (-2,37 %)     TOTALENERGIES 69.270 € (-0,35 %)     BIOMERIEUX 70.100 € (+2,86 %)     NANOBIOTIX 29.960 € (-0,73 %)     SCHNEIDER ELECTRIC 279.550 € (-0,34 %)     NEXITY 8.000 € (+0,38 %)     PHILIPS KON 23.930 € (+1,23 %)     AKZO NOBEL 61.320 € (+0,82 %)     IMPLANET 0.160 € (-10,01 %)     THERACLION 0.659 € (-0,15 %)     BNP PARIBAS ACT.A 103.000 € (+1,52 %)     AMG 33.420 € (-3,69 %)     SOCIETE GENERALE 78.180 € (+2,84 %)     DBV TECHNOLOGIES 2.820 € (-0,77 %)     ASM INTERNATIONAL 991.000 € (+2,25 %)     CRCAM SUD R.A.CCI 238.500 € (-1,47 %)     PERNOD RICARD 66.000 € (-0,36 %)     AYVENS 11.560 € (+0,52 %)     KAUFMAN ET BROAD 23.950 € (-0,62 %)     VALBIOTIS 0.803 € (-5,53 %)     UNILEVER 53.180 € (+0,82 %)     ABN AMRO BANK N.V. 36.930 € (+0,82 %)     TONNER DRONES 0.025 € (-6,82 %)     FLOW TRADERS 25.820 € (-0,69 %)     LVMH 494.400 € (+0,28 %)  
News Réglementées
06/03/2023 14:42

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

06-March-2023 / 13:42 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

02 March 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,332,955

9.33%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,332,955

9.33%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

2,219

110.25 USD

US$0.0001 ordinary shares

Sale

9,284

110.25 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 none

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière